| Acute Leukemia |
1 |
1 |
| Biologic Therapy |
0 |
0.89 |
| Child |
0 |
0.79 |
| CAR-T |
0 |
0.73 |
| Stem Cell Research and Therapy |
0 |
0.8 |
| Toxicology |
0 |
0.47 |
| T-Lymphocyte |
0 |
0.29 |
| Transplantation |
0 |
0.29 |
| Refractory |
0 |
0.26 |
| Cell Transplantation |
0 |
0.23 |
| Acute Lymphoblastic Leukemia |
0 |
0.8 |
| Leukemia |
0 |
0.2 |
| Antigens |
0 |
0.1 |
| Cancer |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Brachial |
0 |
0.03 |
| Chemotherapy |
0 |
0.03 |
| Cytokines |
0 |
0.03 |
| Hematology |
0 |
0.03 |
| Intensive Care Unit (ICU) |
0 |
0.03 |
| Neurotoxicity |
0 |
0.03 |
| New York |
0 |
0.03 |
| Pennsylvania |
0 |
0.03 |
| Residual Disease |
0 |
0.03 |